Real World Study in Locally Advanced or Metastatic NSCLC Patients, Progressed From First-line EGFR-TKI Therapy

Clinical trial NCT04207775 · COMPLETED

Trial details

NCT number: NCT04207775
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Locally Advanced or Metastatic NSCLC

Start date: 2020-03-30
Primary completion: 2023-09-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.